SCHEMBL5740633

SCHEMBL5740633

COC(=O)Oc1cn2ncnc(Nc3cc(CO)ccc3C)c2c1C

nearest known ligand 0.52

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 20/20 0.52
▸ MAPK11 Q15759 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5739216 0.85 KDR (0.55) MAPK14
SCHEMBL1462082 0.84 MAPK14 (0.72) MAPK14MAPK11
SCHEMBL5738412 0.82 MAPK14 (0.51) MAPK14
SCHEMBL5740103 0.81 KDR (0.59) MAPK14
SCHEMBL5739719 0.79 KDR (0.57) MAPK14
SCHEMBL5739951 0.79 KDR (0.71) —
SCHEMBL5740421 0.79 KDR (0.52) MAPK14
SCHEMBL5740927 0.78 KDR (0.56) MAPK14MAPK11
SCHEMBL5740097 0.78 KDR (0.56) MAPK14
SCHEMBL5738800 0.78 KDR (0.48) MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1183033-B1 PYRROLOTRIAZINE INHIBITORS OF KINASES BRISTOL MYERS SQUIBB CO (US) 2006-03-01 — — EP claimed
Send feedback